Adriana Lebkuchen

Fleury S.A. (Brazil)

Papers

3

Total Citations

155

H-Index

3

About

Adriana Lebkuchen is a researcher whose work has made a significant impact in the field of clinical proteomics and infectious disease diagnostics, with a particular focus on mass spectrometry-based methodologies. Rising to prominence during the COVID-19 pandemic, Lebkuchen has been at the forefront of developing rapid, scalable diagnostic tools for SARS-CoV-2 detection. Her most influential contribution, "Establishing a mass spectrometry-based system for rapid detection of SARS-CoV-2 in large clinical sample cohorts" (2020), has garnered 126 citations and introduced a high-throughput targeted proteomics assay capable of detecting SARS-CoV-2 nucleoprotein across large patient populations — a critical advancement during a period of global testing urgency. Complementing this work, her research into fast and low-cost tandem mass spectrometry approaches for SARS-CoV-2 peptide detection further demonstrates her commitment to making diagnostic innovations both accessible and practical for real-world clinical settings. Lebkuchen's research exemplifies the power of proteomics in responding to public health crises, bridging advanced analytical chemistry with urgent medical need, and establishing her as a notable contributor to pandemic-era diagnostic science.

Research Focus

Key Achievements

3
H-Index
3
Papers
155
Total Citations
52
Avg Citations/Paper
🏆 Most Cited Paper
Establishing a mass spectrometry-based system for rapid detection of SARS-CoV-2 in large clinical sample cohorts
126 citations · 2020
📈 Most Prolific Year: 2020 (3 Papers)
🤝 Key Collaborators: 10
🏛 Institutions: Fleury S.A. (Brazil)

Top Papers

  1. 1
  2. 2
  3. 3

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago